Kraj: Wielka Brytania
Język: angielski
Źródło: MHRA (Medicines & Healthcare Products Regulatory Agency)
Calcium folinate
Hospira UK Ltd
V03AF03
Calcium folinate
3mg/1ml
Solution for injection
Intravenous; Intramuscular
No Controlled Drug Status
Valid as a prescribable product
BNF: 08010000; GTIN: 5015997896555
Page 1 of 5 2016-0020386 PACKAGE LEAFLET: INFORMATION FOR THE USER CALCIUM FOLINATE 3 MG/ML INJECTION READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor. IN THIS LEAFLET: 1. What Calcium Folinate Injection is and what it is used for 2. Before you use Calcium Folinate Injection 3. How to use Calcium Folinate Injection 4. Possible side effects 5. How to store Calcium Folinate Injection 6. Further information 1. WHAT CALCIUM FOLINATE INJECTION IS AND WHAT IT IS USED FOR Calcium folinate is one of the B group of vitamins. Calcium Folinate Injection is used to reduce the side effects of other medicines (a group of medicines called folic acid antagonists). Examples of folic acid antagonists are: methotrexate (a medicine often used to treat cancer) trimetrexate (an antibiotic and anti-cancer medicine) trimethoprim (an antibiotic) pyrimethamine (a medicine often used to treat malaria) It may also be used to treat an overdose of these medicines. 2. BEFORE YOU USE CALCIUM FOLINATE INJECTION CALCIUM FOLINATE INJECTION MUST NOT BE INJECTED INTRATHECALLY (INTO THE SPINE). YOU SHOULD NOT BE GIVEN CALCIUM FOLINATE INJECTION IF you have shown signs of hypersensitivity (severe allergy) to calcium folinate in the past you have a particular type of anaemia (pernicious anaemia) caused by too little vitamin B 12 Tell your doctor if either of the above applies to you before this medicine is used. Page 2 of 5 2016-0020386 TAKING/USING OTHER MEDICINES Special care is needed if you are taking/using other medicines as some could interact with Calcium Folinate Injection, for example: folic acid antagonists (see section 1 ‘What Calcium Folinate Injection is and what it is used for’ for examples of these medicines) - the effectiveness of these medicine Przeczytaj cały dokument
OBJECT 1 CALCIUM FOLINATE 3 MG/ML INJECTION Summary of Product Characteristics Updated 29-Jan-2018 | Hospira UK Ltd 1. Name of the medicinal product Calcium Folinate 3 mg/mL Injection 2. Qualitative and quantitative composition Each vial of 1 ml solution contains 3 mg/ml of folinic acid provided as calcium folinate. For excipients, see 6.1_._ 3. Pharmaceutical form Solution for Injection 4. Clinical particulars 4.1 Therapeutic indications Calcium folinate is indicated a) to diminish the toxicity and counteract the action of folic acid antagonists such as methotrexate in cytotoxic therapy and overdose in adults and children. In cytotoxic therapy, this procedure is commonly known as “Calcium Folinate Rescue”; 4.2 Posology and method of administration For intravenous and intramuscular administration only. In the case of intravenous administration, no more than 160 mg of calcium folinate should be injected per minute due to the calcium content of the solution. For intravenous infusion, calcium folinate may be diluted with 0.9% sodium chloride solution or 5% glucose solution before use. Refer also to sections 6.3 and 6.6. _Calcium folinate rescue in methotrexate therapy:_ Since the calcium folinate rescue dosage regimen depends heavily on the posology and method of the intermediate- or high-dose methotrexate administration, the methotrexate protocol will dictate the dosage regimen of calcium folinate rescue. Therefore, it is best to refer to the applied intermediate or high dose methotrexate protocol for posology and method of administration of calcium folinate. The following guidelines may serve as an illustration of regimens used in adults, elderly and children: _Calcium folinate rescue has to be performed by parenteral administration in patients with malabsorption _ _syndromes or other gastrointestinal disorders where enteral absorption is not assured. Dosages above _ _25-50 mg should be given parenterally due to saturable enteral absorption of calcium folinate._ Calcium folinate rescue is necessary when methot Przeczytaj cały dokument